Source comparison
TB-500 Flexibility Results Timeline Expect: Comparison
Week 1–2 No measurable change in range of motion Actin sequestration begins; collagen turnover not yet detectable Biochemical activity present but not functionally measurable. Continue protocol Week 3–4 5–12% improvement in passive joint extension MMP upregula
This comparison does not assign a generated winner or score.
- Week 1–2
- No measurable change in range of motion
- Actin sequestration begins; collagen turnover not yet detectable
- Biochemical activity present but not functionally measurable. Continue protocol
- Week 3–4
- 5–12% improvement in passive joint extension
- MMP upregulation; initial scar tissue degradation
- First objective gains appear. Validate with goniometer measurements
- Week 5–8
- 18–25% cumulative improvement from baseline
- Peak collagen remodeling; organized fiber deposition
- Optimal therapeutic window. Gains accelerate significantly
- Week 9–12
- 28–35% total improvement; gains plateau
- Collagen remodeling reaches equilibrium
- Maximum effect achieved. Further dosing maintains but doesn't increase
- Post-Week 12
- Gains persist if tissue maintained through movement
- Remodeling complete; no additional peptide-driven change
- Maintenance dose optional; flexibility improvements are structurally locked